MarketBeat provided stock performance data and analyst recommendations for Regeneron Pharmaceuticals and IDEAYA Biosciences.

The entities involved

• Regeneron Pharmaceuticals →

  American pharmaceutical company

  • Morgan Stanley dropped price target and Cantor Fitzgerald reduced price target on Regeneron Pharmaceuticals stock.Mon 17:01
  • Regeneron, the FDA, and research institutions are advancing the Ebola response in the DRC through drug approvals and clinical trials.Mon 05:37
• MarketBeat →

  American personal finance blog

  • BlackRock and Dimensional Fund Advisors increased their stakes in Strattec Security, with MarketBeat reporting related stock data.09:05
  • MarketBeat reported the stock's average rating as Benchmark and Jefferies reiterated buy ratings for Bright Minds Biosciences Inc.08:57

Related events

• MarketBeat reported on the financial performance of Donnelley Financial Solutions.Sep 17
• MarketBeat reported an average stock rating for Superior Group of Companies.Sep 17
• MarketBeat reported analyst recommendations, noting that both MarketBeat and Jefferies Financial Group are mid-cap finance companies.Sat 04:38
• MarketBeat provided average rating data for Quince Therapeutics, Inc., following a stock rating boost from Raymond James Financial.Sat 15:42
• MarketBeat provided analyst recommendations for Priority Technology and Freedom.Oct 20